Form D · Pharmaceuticals
Pharminex, L.L.C.
Williamsville, NY · CIK 0001488333
Offering snapshot reported Jan 24, 2013 · SEC filing
- Reported sold
- $3.15M Offering amount: $3.15M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2013 | Initial | $3,147,857 | No comparison | 38 | SEC filing |
| Apr 18, 2011 | Amendment | $4,134,572 | $3,134,572vs Feb 15, 2011 | 64 | SEC filing |
| Feb 15, 2011 | Initial | $1,000,000 | No comparison | 19 | SEC filing |
| Apr 6, 2010 | Initial | $4,025,000 | No comparison | 60 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190719
Source: Form D, filed Jan 24, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bellomo | Director, Executive |
| Charles E Lannon | Director, Executive |
| Jonathan Swiatkowski | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6467 Main Street
Williamsville, NY, 14221
Williamsville, NY, 14221